We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.1B
AUM Growth
+$1.16B
(+5.5%)
Cap. Flow
-$352M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
2,132
New
129
Increased
562
Reduced
821
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$43.5M |
| 2 |
Verisk Analytics
VRSK
|
+$39.9M |
| 3 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$38.6M |
| 4 |
Biogen
BIIB
|
+$38.6M |
| 5 |
VICI Properties
VICI
|
+$34.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Apple
AAPL
|
+$53.4M |
| 3 |
PayPal
PYPL
|
+$37.7M |
| 4 |
Reinsurance Group of America
RGA
|
+$36.6M |
| 5 |
SLB Ltd
SLB
|
+$31.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Real Estate | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Entravision Communication
EVC
$1.02B
| $497K | ﹤0.01% |
103,600
-16,600
| -14% | -$81.4K |
|
1327
REX American Resources
REX
$1.39B
| $497K | ﹤0.01% |
31,200
| – | – |
|
1328
First Bank
FRBA
$470M
| $496K | ﹤0.01% |
36,100
-5,000
| -12% | -$73.7K |
|
1329
MiMedx Group
MDXG
$630M
| $496K | ﹤0.01% |
178,700
| – | – |
|
|
LGTY
1330
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $496K | ﹤0.01% |
33,800
| – | – |
|
1331
iHeartMedia
IHRT
$531M
| $492K | ﹤0.01% |
80,300
| – | – |
|
|
ACH
1332
Accendra Health
ACH
$254M
| $492K | ﹤0.01% |
25,200
| – | – |
|
1333
Twist Bioscience
TWST
$5.32B
| $490K | ﹤0.01% |
20,600
| – | – |
|
1334
Community Health Systems
CYH
$382M
| $487K | ﹤0.01% |
112,900
| – | – |
|
1335
Rackspace Technology
RXT
$960M
| $486K | ﹤0.01% |
165,000
+101,100
| +158% | +$427K |
|
1336
Kodiak Sciences
KOD
$2.5B
| $484K | ﹤0.01% |
67,600
| – | – |
|
1337
MaxCyte
MXCT
$108M
| $484K | ﹤0.01% |
88,800
+28,300
| +47% | +$174K |
|
1338
Titan International
TWI
$492M
| $484K | ﹤0.01% |
31,600
-21,400
| -40% | -$305K |
|
|
LBC
1339
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $484K | ﹤0.01% |
43,600
| – | – |
|
1340
AMN Healthcare
AMN
$1.35B
| $483K | ﹤0.01% |
4,700
-100
| -2% | -$11.5K |
|
1341
Codexis
CDXS
$158M
| $483K | ﹤0.01% |
103,800
+67,000
| +182% | +$367K |
|
|
ONL
1342
Orion Office REIT
ONL
$151M
| $481K | ﹤0.01% |
56,391
-2,435
| -4% | -$22.2K |
|
1343
Castle Biosciences
CSTL
$742M
| $480K | ﹤0.01% |
20,400
| – | – |
|
|
TSE
1344
DELISTED
Trinseo
TSE
| $479K | ﹤0.01% |
21,100
| – | – |
|
1345
SoundThinking
SSTI
$108M
| $477K | ﹤0.01% |
14,100
+1,600
| +13% | +$53.5K |
|
1346
Valhi
VHI
$389M
| $477K | ﹤0.01% |
21,700
+1,600
| +8% | +$38.9K |
|
|
ALX
1347
Alexander's
ALX
$1.36B
| $475K | ﹤0.01% |
2,161
-46
| -2% | -$10.5K |
|
|
BFS
1348
Saul Centers
BFS
$858M
| $474K | ﹤0.01% |
11,665
-656
| -5% | -$26.6K |
|
1349
Intellia Therapeutics
NTLA
$1.51B
| $474K | ﹤0.01% |
13,600
-2,300
| -14% | -$109K |
|
1350
Enel Chile
ENIC
$6.03B
| $472K | ﹤0.01% |
210,000
| – | – |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2022 Portfolio in Review
As of Q4 2022, STRS Ohio held 2,132 positions worth $22.1B, up 5.5% from $21B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
STRS Ohio's Q4 2022 filing shows 129 new, 562 increased, 821 reduced and 155 closed positions. Its largest new stake was Biogen: 136,550 shares worth $37.8M. The largest sale was Microsoft, an estimated $65.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- STRS Ohio's largest Q4 2022 buy was Biogen: 136,550 shares worth $37.8M.
- STRS Ohio added most to Halliburton in Q4 2022, an estimated $43.5M increase.
- STRS Ohio's biggest Q4 2022 reduction was Microsoft, cutting an estimated $65.7M.
- STRS Ohio fully exited Abiomed Inc in Q4 2022, selling an estimated $23.7M.
- STRS Ohio's ten largest holdings make up 19% of its $22.1B portfolio in Q4 2022.
- STRS Ohio opened 129 new positions and closed 155 in Q4 2022.
- STRS Ohio's portfolio value rose 5.5% quarter-over-quarter to $22.1B.
Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.